Ebola | Global Biodefense

Menu

The Coping Mechanisms the DRC is Putting in Place As it Faces Ebola, Measles and COVID-19

FDA Accepts for Priority Review for REGN-EB3 to Treat Ebola

by Global Biodefense Staff April 16, 2020, 4:03 pm
Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform

by Global Biodefense Staff March 3, 2020, 6:04 pm
U.S. Ebola Treatment Center Costs and Sustainability if Federal Funding Withdrawn

by Global Biodefense Staff February 25, 2020, 11:33 pm
Ebola Still Constitutes a Public Health Emergency of International Concern

by Global Biodefense Staff February 16, 2020, 12:04 pm
New Method Predicts Individual Response to Ebola Infection

by Global Biodefense Staff February 16, 2020, 10:05 am
Scientists Find Ally in Fight Against Brain Tumors: Ebola

by Global Biodefense Staff February 16, 2020, 10:01 am
Antibody Mixture May Help Block Ebola Virus Infection

by Global Biodefense Staff February 6, 2020, 1:46 pm
First-Ever Therapeutic Antibody Cocktail for Sudan Virus Shows Promise in Animal Studies

by Global Biodefense Staff February 4, 2020, 4:22 pm
Boston Hospital Only New England Center Designated to Treat Ebola Patients

by Global Biodefense Staff January 22, 2020, 10:08 pm
MSF Update on Ebola Frontline Response

by Global Biodefense Staff January 20, 2020, 1:22 pm
Revocation of Emergency Use Authorizations of Zika, Ebola Diagnostics

by Global Biodefense Staff January 12, 2020, 4:00 pm
Attacks on Health Care Monthly News Brief

by Global Biodefense Staff January 10, 2020, 10:47 pm
The Future Biosecurity Implications of Thousands of Samples Taken During Outbreaks

by Global Biodefense Staff January 10, 2020, 10:47 am
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses

by Global Biodefense Staff January 7, 2020, 7:52 pm

Congratulations. You've reached the end of the internet.

Back to Top

Close